Evonik to close its Kaba site in Hungary
Evonik will stop its amino acid production at its Hungarian Kaba site by the end of April 2018. There Evonik Agroferm Zrt., a subsidiary of Evonik, currently employs about 120 people.
The decision was prompted by intense and increasing competition in the market for the amino acid L-threonine, produced by Evonik in Kaba under the ThreAMINO® brand name. “Despite considerable and continual optimizations, it is no longer possible for Evonik to maintain economic production in Kaba over the long term. Therefore we have decided to stop production in Kaba which is in line with our strategy to secure a leading position for our amino acid business,” says Dr. Emmanuel Auer, head of Evonik’s Animal Nutrition Business Line.
Possible alternatives to the shutdown were explored in depth before taking the decision. Supply of ThreAMINO® to Evonik’s global customers remains assured.
Evonik is working in close conjunction with the works council of Evonik Agroferm Zrt., the local union, and Hungarian authorities to handle the forthcoming redundancies in the most socially acceptable manner possible.
The further use of the site will be explored and decided on in close cooperation with the Hungarian authorities after production has stopped.
Other news from the department manufacturing
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
